img

 

On 25 August, the State Drug Administration (SDA) issued a notification of drug approval for [Spironolactone Tablets], a new Class 3 filing of Zhejiang Shenzhou Pharmaceutical Co.

The Company has officially received the approval letter from the State Drug Administration on 6 September.

Other information